Inhaled and Intranasal Products Contract Service Providers Market, 2030
DUBLIN, Dec. 7, 2020 /PRNewswire/ -- The "Inhaled and Intranasal Products Contract Service Providers Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
DUBLIN, Dec. 7, 2020 /PRNewswire/ -- The "Inhaled and Intranasal Products Contract Service Providers Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
The 'Inhaled and Intranasal Products: Contract Service Providers Market (Focus on Drugs and Drug Delivery Systems), 2020 - 2030' report features an extensive study of the current market landscape and future opportunities for the contract service providers focused on drugs and drug delivery systems. It features an in-depth analysis, highlighting the capabilities of various contract service providers engaged in this domain.
One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the market. Based on parameters, such as overall pulmonary market, global intranasal drug market, cost of goods sold and outsourcing trends, we have provided an informed estimate of the likely evolution of the contract service providers market in the mid to long term, for the time period 2020-2030.
Amongst other elements, the report includes:
- A detailed assessment of the overall landscape of companies offering contract and custom services for the inhaled and Intranasal drug development and manufacturing, along with information on a number of relevant parameters, such as year of establishment, company size, type of service provider (contract manufacturing organization and contract research organization), scale of operation (preclinical, clinical and commercial), location of headquarters, location of manufacturing facilities, type of drug molecule (small molecule and biologic), type of inhaled and intranasal related primary service(s) offered (development, manufacturing, analytical testing/services, device selection/optimization and fill/finish and packaging), type of inhaled and intranasal related secondary service(s) offered (process development, pre-formulation development, formulation development, pre-formulation manufacturing, formulation manufacturing, particle engineering, product characterization, extractable and leachable studies, stability testing and plume geometry measurement), type of formulation (powder, aerosol and liquid), type of dosage form (metered dose inhaler, dry powder inhaler, nebulizer, soft mist inhaler, nasal spray, nasal drops, nasal powder and others), route of administration (oral and intranasal inhalation) and installed capacity and batch size (if available).
- A detailed assessment of the overall landscape of the companies offering contract services for the inhaled and intranasal drug delivery system manufacturing, along with information on a number of relevant parameters, such as year of establishment, company size, scale of operation (precommercial and commercial), location of headquarters, location of manufacturing facilities, type of inhaled and intranasal drug delivery system related service(s) offered (design, development, manufacturing, assembly, fill/finish and packaging), type of formulation (powder, aerosol and liquid) and type of drug delivery system used (metered dose inhaler, dry powder inhaler, nebulizer, nasal spray and others).
- A competitiveness analysis of inhaled and intranasal drug product contract service providers across key geographical areas, featuring a four-dimensional bubble representation, taking into consideration service strength (number of services offered, type of formulation(s) offered and route of administration), manufacturing strength (type of drug molecule, scale of operation, number of manufacturing facilities), supplier strength (company size and its experience in this field) and company size (small-sized, mid-sized and large).
- Tabulated profiles of some of the key contract manufacturers (shortlisted based on a proprietary criterion) that offer a diverse range of capabilities for the development, manufacturing and packaging of inhaled and intranasal drugs across North America, Europe and Asia-Pacific. Each profile features an overview of the company, along with information related to its financial performance (if available), service portfolio, products and intranasal related capabilities, type of drug molecule, type of dosage form, inhaled and intranasal products related manufacturing facilities, recent developments and an informed future outlook.
- An analysis of the various partnerships related to inhaled and intranasal contract service providers, which have been established since 2015, based on several parameters, such as year of agreement, type of partnership (development agreements, manufacturing agreements, merger and acquisition, licensing agreement, commercialization, research and development agreements, service alliance, joint venture and other agreements), scale of operation (preclinical, clinical and commercial), type of inhaled and intranasal related service(s) offered (development, manufacturing, analytical testing/services and fill/finish and packaging), type of dosage form (metered dose inhalers, dry powder inhalers, nebulizers and others) and most active players. It also provides the regional distribution of the players involved in the collaborations.
- A qualitative analysis highlighting the various factors that need to be taken into consideration by inhaled and intranasal product developers, while deciding whether to manufacture their respective products in-house or engage a contract service provider.
- An estimate of the global, inhaled and intranasal product demand, based on the type of product (inhaled and intranasal), type of drug delivery system used (metered dose inhalers, dry powder inhalers, nebulizers and nasal sprays) and key geographical regions (North America, Europe and Asia-Pacific).
- An insightful discussion on the impact of COVID-19 outbreak on the inhaled and intranasal service providers. In addition, it features various strategies that different companies have adopted/may adopt in order to mitigate the challenges affiliated to the current global crisis.
Key Questions Answered
- Who are the leading contract service providers offering inhalable and intranasal products related services, across the world?
- In which regions are majority of the inhaled and intranasal product related manufacturing facilities located?
- What percentage of inhaled and intranasal manufacturing operations are outsourced?
- Which partnership models are commonly adopted by stakeholders in this industry?
- What is the impact of COVID-19 outbreak on inhaled and intranasal product services market?
- What is the current, global demand for inhaled and intranasal products?
- How is the current and future market opportunity likely to be distributed across key market segments?
Key Topics Covered:
1. Preface
2. Executive Summary
3. Introduction
4. Inhaled And Intranasal Drug Product Service Providers: Market Landscape
5. Inhaled And Intranasal Drug Delivery System Manufacturing Service Providers: Market Landscape
6. Company Competitiveness Analysis
7. Inhaled And Intranasal Contract Manufacturing Service Providers In North America
8. Inhaled And Intranasal Contract Manufacturing Service Providers In Europe And Asia-Pacific
9. Partnerships And Collaborations
10. Make Versus Buy Decision Making
11. Demand Analysis
12. Market Forecast And Opportunity Analysis
13. Impact Of Covid-19 Pandemic On The Inhaled And Intranasal Service Providers Market
14. Conclusion
15. Executive Insights
16. Appendix 1: Tabulated Data
Companies Mentioned
- 3M
- 3P innovation
- Actelion Pharmaceuticals
- Aerami Therapeutics (formerly Dance Biopharm)
- Aerosol Research and Engineering Laboratories
- Akums Drugs & Pharmaceuticals
- Alcami
- Alpic Biotech
- Altaris Capital Partners
- Altimmune
- Amneal Pharmaceuticals
- Aptar Pharma
- Arch Biopartners
- Arcturus Therapeutics
- ASM Aerosol-Service
- Aspen Pharmacare
- AstraZeneca
- Atossa Therapeutics
- Aurohealth
- Basic Pharma
- Battelle
- Bespak
- Beximco Pharmaceuticals
- BioCare Group
- Biofilms Research Center for Biointerfaces, Malmo University
- Boehringer Ingelheim
- Breath Therapeutics
- Capsugel
- Carclo Technical Plastics
- Catalent
- CF PharmTech
- Charles River Laboratories
- Chemic Laboratories
- Chiesi Farmaceutici
- Chromcore Lifesciences
- Cirrus Pharmaceuticals
- COC Farmaceutici
- Colep
- Confab
- Consort Medical
- Contract Pharmaceuticals
- Creative Biolabs
- Circassia
- CrystecPharma
- Curida
- CytoAgents
- Dalton Pharma Services
- DFE Pharma
- Doctor Pack
- Dorizoe Lifesciences
- DPT Laboratories
- Dr. Reddy's Laboratories
- DRK Pharma Solutions
- Dwarkesh Pharmaceuticals
- EKG Life Science Solutions
- Elfin Drugs
- Emmace Consulting
- Ennaid Therapeutics
- Ethris
- Eurofins
- Evoke Pharma
- Evonik
- Experic
- Farbe Firma
- FAMAR
- Focus Inhalation
- Forefront Medical Technology
- Forest Laboratories
- Genentech
- Gerresheimer
- Getron Pharmaceuticals
- Gilead Sciences
- GlaxoSmithKline
- Global Pharma
- Hikma Pharmaceuticals
- Horizon Pharmaceuticals
- Hovione
- Humanigen
- Iconovo
- IIT Research Institute (IITRI)
- Impopharma
- Importfab
- Inhalexpert
- InhaTarget Therapeutics
- Insmed
- Intas Pharmaceuticals
- Intertek
- Invion
- iPharma
- ITC Farma
- J Pharmaceuticals
- Jabil
- Jagotec
- Janssen Pharmaceuticals
- Johnson & Johnson
- Kiel University
- Kindeva Drug Delivery
- King's College London
- Kymos Pharma Services
- Labiana Pharmaceuticals
- Lamda Laboratories
- Lannet Technologies
- LEAX Group
- Lepharm
- Life Vision Healthcare
- Lindal Group
- Liquidia Technologies
- Lomapharm
- Lonza
- Lovelace Biomedical
- Lxir Medilabs (A unit of SMM Life Sciences)
- M2M Pharmaceuticals
- Macter International
- Malmo University
- MannKind
- Mapaex
- Maya Biotech
- McMaster University
- Medicair Bioscience Laboratories
- Medicilon
- Medlab Pharmaceuticals
- MedPharm
- Menarini Group
- Merck
- Micro-Sphere
- MidasCare
- Mipharm
- MMG Healthcare
- Moderna Therapeutics
- Molex
- Medicon Valley Inhalation Consortium (MVIC)
- Mylan
- Nanologica
- Nanopharm
- Napp Pharmaceuticals
- Nelipak Healthcare Packaging
- Nelson Laboratories
- Nemera
- Nephron Pharmaceuticals
- Neurelis
- Neurimmune
- Newtec Pro Manufacturing
- Next Breath
- Nipro
- Nitto Medic
- Nivon Specialties
- Noble
- Novartis
- One Pharma
- Orion
- Ote Pharma
- Optinose
- Paragon Nordic
- PARI Pharma
- PCI Pharma Services
- Penta Arzneimittel
- Pfizer
- Pharma Stulln
- Pharma Tech
- PharmaCielo
- Pharmaserve
- Pharmaterials
- PHAST (Acquired by Eurofins)
- Phillips-Medisize
- Pine Lake Laboratories
- Polyphor
- PPD Laboratories
- Probiotec
- Propeller Health
- Proveris Scientific
- Pulmatrix
- PulmoFlow
- Pursuit Pharma
- Pushkar Pharma
- Quotient Sciences
- Recipharm
- Renaissance Pharmaceuticals
- Roche
- Rommelag
- Rubicon Research
- S.R.Chemicals and Pharmaceuticals
- SAFE Pharmaceutical
- Salvat
- Sandoz
- Sanofi
- Sciarra Laboratories
- Seikagaku
- Sentiss Pharma
- Servier Pharmaceuticals
- SHL Group
- Simpler Consulting
- SkyePharma
- Smithers
- Spicona
- Stabicon Life Sciences
- Stevanato Group
- Summit Biosciences
- Sunovion
- Sunovion Pharmaceuticals
- Synerlab
- Takeda
- Teva Pharmaceuticals
- The Indian Pharmaceutical Association
- The Ritedose Corporation
- Theravance Biopharma
- Tinuum
- Toxikon
- Trillium Health Care Products
- UCB Pharma
- Ultratech India
- United Therapeutics
- University of Birmingham
- University of Copenhagen
- University of Cyprus
- University of Florida
- University of Turku
- Bausch Health (formerly Valeant Pharmaceuticals)
- Vectura
- ViralClear Pharmaceuticals (A subsidiary of BioSig Technologies)
- Vinventions
- Vivimed
- West Coast Pharmaceutical
- Westmed Medical Group
For more information about this report visit https://www.researchandmarkets.com/r/63lzod
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/inhaled-and-intranasal-products-contract-service-providers-market-2030-301187280.html
SOURCE Research and Markets